Climb Bio Inc <CLYM.O>: B. Riley Raises Target Price to $30 From $26
CLYM•Related News
8x8 to host investor webcast on recent product innovations, long-term financial model
EGHT•
ASA Gold board backs conversion to credit-focused BDC strategy
ASA•
MiddleGame Ventures says AI strengthens fintech moats as software defenses erode
XLF•
Dollar bounces as US jobs growth beats expectations
SPY•
Classroom furniture maker Virco's Q2 revenue falls, cites cautious school spending
VIRC•